MMP13 and atrial fibrillation: Furthermore, treatment of human NP and AF cells with 10 ng/ml recombinant IL-1β has shown increased expression of MMP-3, MMP-13 and ADAMTS-4 as well as decreased expression of aggrecan, collagen II, collagen I, and SOX6 [42].